app.rxdatalab.com · Free public feature
Regulatory filings linked to clinical programs and markets. Trials, SEC filings, insider activity, and market data from primary sources.
BioHedge
Hedge fund positioning from Schedule 13D/13G filings. Each position cross-referenced with clinical trial events, regulatory filings, and insider trades. Free public view — the full platform adds company profiles, trial history, competitive landscape, and financing tracker for 500+ biotech companies.
Activity Summary
Multi-Fund Activity
Companies with two or more institutional investors filing in the same period.
Filing Volume by Week
|
Filed
|
Fund | Company | Position | Gap |
|---|---|---|---|---|
|
Jul 31, 2026
Event: 06/30/2026
Filed: Jul 31, 2026 |
ESTA
ESTABLISHMENT LABS HLDGS INC
|
owns 9.2% NEW | — | |
|
ESTA
ESTABLISHMENT LABS HLDGS INC
9.2%
NEW
|
||||
|
Jul 31, 2026
Event: 06/30/2026
Filed: Jul 31, 2026 |
KTTA
Pasithea Therapeutics Corp.
|
owns 6.1% | — | |
|
KTTA
Pasithea Therapeutics Corp.
6.1%
|
||||
|
Jul 31, 2026
Event: 06/30/2026
Filed: Jul 31, 2026 |
CNTX
Context Therapeutics Inc.
|
owns 3.3% ▼-2.4 | 78d | |
|
CNTX
Context Therapeutics Inc.
3.3%
▼-2.4
78d
|
||||
|
Jul 31, 2026
Event: 07/29/2026
Filed: Jul 31, 2026 |
IKT
INHIBIKASE THERAPEUTICS INC
|
owns 9.9% ▼-6.0 | 14d | |
|
IKT
INHIBIKASE THERAPEUTICS INC
9.9%
▼-6.0
14d
|
||||
|
Jul 31, 2026
Event: 06/30/2026
Filed: Jul 31, 2026 |
HROW
Harrow, Inc.
|
owns 6.4% | — | |
|
HROW
Harrow, Inc.
6.4%
|
||||
|
Jul 29, 2026
Event: 07/22/2026
Filed: Jul 29, 2026 |
GOSS
GOSSAMER BIO INC
|
owns 5.1% NEW | — | |
|
GOSS
GOSSAMER BIO INC
5.1%
NEW
|
||||
|
Jul 29, 2026
Event: 06/30/2026
Filed: Jul 29, 2026 |
DTIL
PRECISION BIOSCIENCES INC
|
owns 5.0% ▼-2.6 | 105d | |
|
DTIL
PRECISION BIOSCIENCES INC
5.0%
▼-2.6
105d
|
||||
|
Jul 28, 2026
Event: 06/30/2026
Filed: Jul 28, 2026 |
PMVP
PMV Pharmaceuticals, Inc.
|
owns 4.9% ▼-0.8 | 85d | |
|
PMVP
PMV Pharmaceuticals, Inc.
4.9%
▼-0.8
85d
|
||||
|
Jul 28, 2026
Event: 06/30/2026
Filed: Jul 28, 2026 |
ADGM
Adagio Medical
|
owns 3.1% ▼-2.9 | 167d | |
|
ADGM
Adagio Medical
3.1%
▼-2.9
167d
|
||||
|
Jul 24, 2026
Event: 07/22/2026
Filed: Jul 24, 2026 |
ATRA
ATARA BIOTHERAPEUTICS INC
|
owns 9.9% | 71d | |
|
ATRA
ATARA BIOTHERAPEUTICS INC
9.9%
71d
|
||||
Understanding Schedule 13D and 13G Filings
Schedule 13D and 13G filings are SEC disclosures required when an investor acquires more than 5% of a company's outstanding shares.
Schedule 13D (Activist)
Filed when an investor may seek to influence management, board composition, or corporate strategy. Requires disclosure of investment purpose and plans.
Schedule 13G (Passive)
Filed by passive investors (mutual funds, index funds, institutions) with no intent to influence. Simpler filing requirements.
Gap column: Days since previous filing for the same fund+company pair.
Data source: SEC EDGAR. Filings typically available within 4 hours of submission.
This page reflects disclosed ownership changes only. Absence of activity does not imply absence of interest.
Intelligence Platform
Every event, in context.
Cross-reference each company's trial history, SEC filings, insider trades, and fund positioning in one view. Traceable to primary sources.